The new Medicare payment model aims to take down wasteful spending, but Congress and analysts point out potential problems.
Richard Payerchin
Advertisement
Richard Payerchin is editor of Medical Economics.
Articles by Richard Payerchin
Advertisement
Latest Updated Articles
Advertisement
Advertisement
Trending on Pharmaceutical Commerce
1
Why Direct-to-Patient Is the Pharma Industry’s Next Power Move
2
Pharma Pulse: Manufacturing Front-Loading and the Smart Speaker Intervention
3
FDA Reviews ImportShield Program as Processing Gains Boost Import Oversight and Supply Chain Protection
4
Pharma Industry Uncertainty in Wake of On/Off Greenland Tariffs
5